ロード中...

Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain

Pain often accompanies cancer and most current therapies for treating cancer pain have significant unwanted side effects. Targeting nerve growth factor (NGF) or its cognate receptor tropomyosin receptor kinase A (TrkA) has become an attractive target for attenuating chronic pain. In the present repo...

詳細記述

保存先:
書誌詳細
主要な著者: Ghilardi, Joseph R, Freeman, Katie T, Jimenez-Andrade, Juan M, Mantyh, William G, Bloom, Aaron P, Kuskowski, Michael A, Mantyh, Patrick W
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2010
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3004846/
https://ncbi.nlm.nih.gov/pubmed/21138586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1744-8069-6-87
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!